• 대한방사선방어학회:학술대회논문집
• /
• 2009.11a
• /
• pp.38-39
• /
• 2009

• Journal of agricultural medicine and community health
• /
• v.39 no.1
• /
• pp.46-58
• /
• 2014

Objectives: This study was aimed to analyze the trends of cancer incidence and evaluate the quality control of cancer registration data in Jeollabuk-do from 2001 to 2010. Methods: Incidence data of all cancers and indices of quality of cancer registration data in Jeollabuk-do for the 10-year period were obtained from the Population-based Regional Cancer Registry in the Jeonbuk Regional Cancer Center. Trends in crude incidence rate (CR) and age-standardized incidence rate (ASR) for all cancers and incidence rates for major cancer sites by gender were analyzed. Joinpoint regression tool was used to describe and quantify trends. And the completeness and validity of cancer registration data were analyzed. Results: The major cancer sites in males were the stomach (22.2%), lung (16.6%), colorectum (12.8%), liver (12.3%) and prostate (6.2%), and in females were the thyroid (17.8%), stomach (14.7%), breast (11.6%), colorectum (11.5%) and lung (7.7%). Between 2001 to 2010, ASR for all cancers increased 13.7% in men, 68% in women, and 36.5% overall. ASR for all cancers increased by 1.2% per year in males and by 6.7% per year in females from 2001 to 2010. In the quality control of the cancer registration data between 2001 and 2010, death certificate only (DCO%) for men was decreased from 5.6% to 1.3% and DCO% for women decreased from 6.1% to 1.8%. Microscopic verification (MV%) increased in both men and women. And mortality/incidence ratio (MI%) declined in both men and women. Conclusions: The cancer incidence during the 10 years (2001-2010) in Jeollabuk-do was increasing especially for the colorectum and prostate in men, and for the thyroid and breast in women. The overall quality control of the cancer registry was gradually improving.

• 대한예방의학회:학술대회논문집
• /
• 2002.10a
• /
• pp.516-517
• /
• 2002

• Proceedings of the Korean Journal of Food and Nutrition Conference
• /
• 1997.06b
• /
• pp.18-21
• /
• 1997

오늘날 최신 의료기술 및 과학의 발달로 인간의 수명이 연장되는 것에 비해 암 발생률은 세계적으로 증가추세에 있다. 암은 인류의 1/3을 사망하게 하는 주요원인으로 인류공동의 관심사이며 온 세계의 과학자나 의학자들에게 주어진 최대 과제이기도 하다. 암발생률과 사망률을 국가별로 살펴보면 미국의 경우 1년에 약 1백만명 정도가 암에 걸리고 그 중 약 45만명 정도가 암으로 사망하고 있는 것으로 보고되고 있으며 일본은 1981년부터 사망 원인 1위가 암으로 밝혀진 후 연간 약 22만명 정도가 암으로 사망하고 있다. 우리 나라 역시 1988년부터 암이 병인별 사망원인 1위가 된 후 최근 1995년에는 인구 10만명당 1413명이 암으로 사망하고 있는 것으로 나타났다. 암의 발병원인은 여러 가지가 있지만 유전적인 요소와 같은 내적 요인보다는 환경적 요인에 의한 발행이 더 큰 원인이 되고 있으며 환경적 요인 중에서도 매일 반복해서 섭취하는 음식물은 매우 중요한 부분을 차지하고 있다. 따라서 우리의 일상적인 식생활에 좀 더 주의한다면 암의 원인이 될 수 있는 식사를 암을 예방할 수 있는 식사로 바꿀 수 있을 것이다.

• Journal of the Korean Data and Information Science Society
• /
• v.27 no.5
• /
• pp.1169-1182
• /
• 2016

Cancer is a typical cause of death in Korea that becomes a major issue in health care. According to Cause of Death Statistics (2014) by National Statistical Office, SMRs (standardized mortality rates) in Busan were counted as the highest among all cities. In this paper, we used data of Busan Regional Cancer Center to estimate the extent of the cancer incidence rate and cancer mortality rate. The data are considered in small areas of administrative units such as Gu/Dong from years 2003 to 2009. All cancer including four major cancers (stomach cancer, colorectal cancer, lung cancer, liver cancer) have been analyzed. We carried out model selection and parameter estimation using spatial multi-level model incorporating a spatial correlation. For the spatial effects, CAR (conditional autoregressive model) has been assumed.

• Korean Journal of Clinical Pharmacy
• /
• v.29 no.3
• /
• pp.186-192
• /
• 2019

Background: Diabetes is associated with cancer risk in the aging population. Observational studies have indicated the beneficial effects of metformin against breast cancer, making studies on the anticancer potential of antidiabetic drugs worthwhile. This study investigated cancer incidence in patients on antidiabetic monotherapy. Methods: Using National Health Insurance Service data (2002-2013), a retrospective cohort study that included type 2 diabetes mellitus (T2DM) patients was conducted. Study subjects were enrolled if they were ${\geq}30$ years old, on monotherapy for diabetes, and cancer-free. They were followed up for cancer occurrence or death, until December 31st, 2013. A Cox proportional hazard model analysis was conducted between metformin and sulfonylurea (including meglitinide) users, to determine cancer risk, with adjustment for age, gender, comorbidity index, dyslipidemia, hypertension, and T2DM duration. Results: The number of antidiabetic monotherapy-treated T2DM patients without a history of cancer was 9,554 (metformin, n = 5,825; sulfonylurea, n = 3,225; others, n = 504). During the follow-up period (mean, 2.04; IQR, 3.18 years), the cancer incidence rate was 5.48/100 and 5.45/100 patient-years for metformin and sulfonylurea, respectively. The hazard ratio (HR) for risk of cancer incidence in the metformin group was 0.74 (95% confidence interval [CI], 0.66-0.83; p < 0.0001), compared with sulfonylurea. Additionally, the HRs for risks of lung, liver, and stomach cancer were respectively 0.46 (95% CI, 0.31-0.66; p < 0.0001), 0.41 (95% CI, 0.31-0.54; p < 0.0001), and 0.51 (95% CI, 0.35-0.73; p = 0.0003). Conclusion: Antidiabetic therapy with metformin reduces cancer risk by 26%, specifically for lung, liver, and stomach cancer.

• Journal of Preventive Medicine and Public Health
• /
• v.32 no.4
• /
• pp.482-490
• /
• 1999

Objectives : This paper presents the information on the incidence of cancer from the population-based cancer resistry in Kangwha County. Material and methods : This investigation is based on Kangwha cancer registry. The data included cases of cancer diagnosed from 1986 through 1992. The diagnosis of cancer was confirmed by a team of physicians and nurses with the medical records kept in the clinics and hospitals based on the diagnostic criteria recommended by WHO. Home visitings were also made to cancer patients confirmed in every 6 months for the follow up and for the collection of relevant information directly from the patients. Results : A total of 992 cancer cases were registered during 1986-1992. The age-adjusted cancer incidence rate of all site is 201.7 in men and 110.7 in women. The most common cancer is the stomach cancer in both sexes. The age-adjusted incidence rate of the stomach cancer is 65.9 in men and 25.0 in women per 100,000 population. The lung cancer(33.8) and liver cancer(27.7) are next common cancers in men. The cervical cancer(21.8) and lung cancer(8.4) are next in women. Conclusion : The most common cancer is the stomach cancer in both sexes. The annual age-adjusted incidence rate of the stomach cancer is 65.9 in men and 25.0 in women per 100,000 population.

• Journal of Radiation Protection and Research
• /
• v.29 no.4
• /
• pp.221-230
• /
• 2004

The probability of causation(PC) is the measure to ascertain the likelihood that a particular cancer may be attributed to a particular prior exposure to radiation. Since the PC is involved in several uncertainties, it is desirable to use the confidence limit for the PC, not a point estimate for determining whether to award compensation. We developed the program for estimating the PC to Korean radiation workers with cancer, the so-called RHRI-PEPC, which is based on the most reasonable model for radiation cancer risk and recent Korean baseline data. RHRI-PEPC gives us the upper confidence limit for the PC after adjusting several uncertainties and therefore we can assess more reasonably the causality of radiation exposure for cancer occurred in Korean radiation workers.

• The Korean Journal of Nuclear Medicine Technology
• /
• v.14 no.1
• /
• pp.78-82
• /
• 2010

Purpose: Recently, South Korea has seen a rapidly increased incidence of both breast and thyroid cancers. As a result, the I-131 scan and lymphoscintigraphy have been performed more frequently. Although this type of diagnostic imaging is prominent in that visualizes pathological conditions, which is similar to previous nuclear diagnostic imaging techniques, there is not much anatomical information obtained. Accordingly, it has been used in different ways to help find anatomical locations by transmission scan, however the results were unsatisfactory. Therefore, this study aims to realize an imaging technique which shows more anatomical information through the fusion of gamma and realistic imaging. Materials and Methods: We analyzed the data from patients who were examined by the lymphoscintigraphy and I-131 additional scan by Symbia Gamma camera (SIEMENS) in the nuclear medicine department of the National Cancer Center from April to July of 2009. First, we scanned the same location in patients by using a miniature camera (R-2000) in hyVISION. Afterwards, we scanned by gamma camera. The data we obtained was evaluated based on the scanning that measures an agreement of gamma and realistic imaging by the Gamma Ray Tool fusion program. Results: The amount of radiation technicians and patients were exposed was generated during the production process of flood source and applied transmission scan. During this time, the radiation exposure dose of technicians was an average of 14.1743 ${\mu}Sv$, while the radiation exposure dose of patients averaged 0.9037 ${\mu}Sv$. We also confirmed this to matching gamma and realistic markers in fusion imaging. Conclusion: Therefore, we found that we could provide imaging with more anatomical information to clinical doctors by fusion of system of gamma and realistic imaging. This has allowed us to perform an easier method in which to reduce the work process. In addition, we found that the radiation exposure can be reduced from the flood source. Eventually, we hope that this will be applicable in other nuclear medicine studies. Therefore, in order to respect the privacy of patients, this procedure will be performed only after the patient has agreed to the procedure after being given a detailed explanation about the process itself and its advantages.

• Progress in Medical Physics
• /
• v.24 no.1
• /
• pp.1-24
• /
• 2013

As image-guided radiation therapy (IGRT) has been commonly used for more accurate patient setup and monitoring tumor movement during radiation therapy, the necessity for management of imaging dose is increased. However, it has not been an interest issue to radiation therapy communities because the imaging dose is much lower than the therapeutic dose. However, since the cumulative dose from 4DCT and repeated imaging for daily setup verificationin would not be ignorable, appropriate dose management based on ALARA (As Low As Reasonably Achievable) principle is required. In this study, we aimed that (1) survey on imaging equipments and modalities used for IGRT, (2) estimation of IGRT imaging dose depending on treatment types and equipments, (3) collecting data of effective dose on treatment sites from each equipment and imaging protocol, and thus finally provide guideline for imaging dose reduction and optimization.